Company / Capital Expenditures
RAPID MICRO BIOSYSTEMS, INC. Capital Expenditures History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$1.4M
FY2025
5-year range
$690.0K / $6.7M
FY2021-FY2025
Trend
-26.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $7M to $1M over the past 2 years.
Based on SEC 10-K filings.
$1M in FY2025 with a 3-year CAGR of -24.9%.
Declined from $7M to $1M over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -24.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -24.9%, indicating a declining trend.
- In FY2025, capital expenditures decreased 26.0% year-over-year.
- Peak capital expenditures was recorded in FY2023.
- Lowest capital expenditures in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -64.58 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4M | -26.0% |
| FY2024 | $1.8M | -72.6% |
| FY2023 | $6.7M | +109.5% |
| FY2022 | $3.2M | +366.2% |
| FY2021 | $690.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026